RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR EGF AND ERBB-2 RECEPTORS INHIBIT IN-VIVO AND IN-VITRO TUMOR-CELL GROWTH

被引：0
|
作者：
HYNES, NE
MARTE, BM
HELLMANN, P
BEERLI, R
GRONER, B
WELS, W
机构：
[1] FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND
[2] TUMOR BIOL CTR,D-79011 FREIBURG,GERMANY
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1994年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：237 / 237
页数：1
相关论文
共 23 条
  • [1] RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR THE EGF RECEPTOR AND ERBB-2
    SCHMIDT, M
    HYNES, NE
    GRONER, B
    WELS, W
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 73 - 73
  • [2] SELECTIVE-INHIBITION OF TUMOR-CELL GROWTH BY A RECOMBINANT SINGLE-CHAIN ANTIBODY-TOXIN SPECIFIC FOR THE ERBB-2 RECEPTOR
    WELS, W
    HARWERTH, IM
    MUELLER, M
    GRONER, B
    HYNES, NE
    CANCER RESEARCH, 1992, 52 (22) : 6310 - 6317
  • [3] MONOCLONAL-ANTIBODIES DIRECTED TO THE ERBB-2 RECEPTOR INHIBIT IN-VIVO TUMOR-CELL GROWTH
    HARWERTH, IM
    WELS, W
    SCHLEGEL, J
    MULLER, M
    HYNES, NE
    BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1140 - 1145
  • [4] A bivalent single-chain antibody toxin specific for ErbB-2 and the EGF receptor
    Schmidt, M
    Hynes, NE
    Groner, B
    Wels, W
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (04) : 538 - 546
  • [5] IN-VITRO AND IN-VIVO ACTIVITY OF A RECOMBINANT TOXIN, OLX-209, WHICH TARGETS THE ERBB-2 ONCOPROTEIN
    FISCHER, PH
    BIRD, RE
    KASPRZYK, PG
    KING, CR
    TURNER, NA
    PASTAN, I
    KIHARA, A
    BATRA, J
    ADVANCES IN ENZYME REGULATION, VOL 34, 1994, 34 : 119 - 128
  • [6] CYCLOSPORINE-A AND KETOCONAZOLE IMMUNOSUPPRESSION OF TUMOR-CELL GROWTH IN-VITRO - PREDICTION OF ANTICANCER EFFECT IN-VIVO
    MANNING, LS
    ODONOGHUE, HL
    CLARINGBOLD, PG
    TURNER, JH
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 90 - 90
  • [7] Recombinant antibody toxins specific for ERBB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo
    Azemar, M
    Schmidt, M
    Arlt, F
    Kennel, P
    Brandt, B
    Papadimitriou, A
    Groner, B
    Wels, W
    INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (02) : 269 - 275
  • [8] IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HUMAN ANTI-C-ERBB-2 SINGLE-CHAIN FV ISOLATED FROM A FILAMENTOUS PHAGE ANTIBODY LIBRARY
    SCHIER, R
    MARKS, JD
    WOLF, EJ
    APELL, G
    WONG, C
    MCCARTNEY, JE
    BOOKMAN, MA
    HUSTON, JS
    HOUSTON, LL
    WEINER, LM
    ADAMS, GP
    IMMUNOTECHNOLOGY, 1995, 1 (01): : 73 - 81
  • [9] Sampling from single-cell observations to predict tumor cell growth in-vitro and in-vivo
    Pearson, Alexander T.
    Ingram, Patrick
    Bai, Shoumei
    O'Hayer, Patrick
    Chung, Jaehoon
    Yoon, Euisik
    Jackson, Trachette
    Buckanovich, Ronald J.
    ONCOTARGET, 2017, 8 (67) : 111176 - 111189
  • [10] HIGHLY SPECIFIC IN-VIVO TUMOR TARGETING BY MONOVALENT AND DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV
    ADAMS, GP
    MCCARTNEY, JE
    TAI, MS
    OPPERMANN, H
    HUSTON, JS
    STAFFORD, WF
    BOOKMAN, MA
    FAND, I
    HOUSTON, LL
    WEINER, LM
    CANCER RESEARCH, 1993, 53 (17) : 4026 - 4034
123